再鼎医药合计发行850万股

Core Viewpoint - Zai Ding Pharmaceutical (09688) announced the issuance of new shares to fulfill stock incentive plans and options granted to executive directors [1] Group 1: Share Issuance Details - On February 4, 2026, the company will issue 3.8891 million new shares held by a trustee to fulfill the stock awards granted under the 2017, 2022, and 2024 equity incentive plans [1] - Additionally, on the same date, the company will issue 4.6109 million new shares held by a trustee to fulfill the stock awards and options granted to executive directors under the 2015, 2017, 2022, and 2024 equity incentive plans [1]